Protara Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Protara's estimated annual revenue is currently $3.8M per year.(i)
  • Protara's estimated revenue per employee is $112,000

Employee Data

  • Protara has 34 Employees.(i)
  • Protara grew their employee count by -6% last year.

Protara's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
2
CEOReveal Email/Phone
3
SVP, Investor Relations and Corporate Affairs Protara TherapeuticsReveal Email/Phone
4
General Counsel and Corporate SecretaryReveal Email/Phone
5
SVP, Investor Relations and Corporate AffairsReveal Email/Phone
6
SVP & Chief People OfficerReveal Email/Phone
7
Senior Director Clinical OperationsReveal Email/Phone
8
Co-founder & Chief Scientific Operations OfficerReveal Email/Phone
9
Associate Director, Clinical ScientistReveal Email/Phone
10
Medical Director Clinical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27.2M181-36%$162.2MN/A
#2
$3.8M340%N/AN/A
#3
$60.8M34212%$800MN/A
#4
$3.6M32-6%N/AN/A
#5
$53.7M302-16%$26.9MN/A
#6
$2.8M29-31%N/AN/A
#7
$197M1454-5%$112.6MN/A
#8
$22.6M150-8%$45MN/A
#9
$21.6M0N/A$13.2MN/A
#10
$4070M4114-6%$1.9BN/A
Add Company

What Is Protara?

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara's portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$3.8M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Protara News

2022-03-22 - Protara Therapeutics Doses First Patient in ADVANCED-1 ...

NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative...

2022-03-22 - Protara Therapeutics Announces Fourth Quarter and Full Year ...

Protara Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Business Overview. March 09, 2022 07:30 ET | Source: Protara...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.9M3410%N/A
#2
$3.6M3417%$33.8M
#3
$5.9M34-41%$13.3M
#4
$3.5M340%N/A
#5
$3.5M34-17%N/A